CSPAM
BSX icon

Cary Street Partners Asset Management’s Boston Scientific BSX Stock Holding History

Cary Street Partners Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-58
Closed -$2K – 445
2022
Q3 		$2K Buy
+58
New +$2.33K ﹤0.01% 386

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Cary Street Partners Asset Management's BSX Position: Q4 2022 in Review

Cary Street Partners Asset Management sold out of Boston Scientific (BSX) in Q4 2022, closing a stake of 58 shares — an estimated $2K sold.

Cary Street Partners Asset Management first reported a position in BSX in Q3 2022 and held it in 1 quarter. The position peaked at $2K in Q3 2022. 930 funds tracked by Wall St. Rank hold BSX as of Q4 2022.

  • Cary Street Partners Asset Management reported no remaining Boston Scientific position as of Q4 2022 after selling out during the quarter.
  • Cary Street Partners Asset Management sold 58 Boston Scientific shares in Q4 2022, an estimated $2K.
  • Cary Street Partners Asset Management first reported a position in Boston Scientific in Q3 2022 and held it in 1 quarter.
  • Cary Street Partners Asset Management's Boston Scientific position peaked at $2K in Q3 2022.
  • 930 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.

Based on Cary Street Partners Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.